[1]
P. Dey Sarkar and G. K. Gupta, “A Pilot Study Indicating Valuation of C‑Reactive Protein for Disease Outcome in Sickle Hemoglobin Patients of Central India”, J. Drug Delivery Ther., vol. 10, no. 2-s, pp. 35–38, Apr. 2020, doi: 10.22270/jddt.v10i2-s.4030.